Introduction
Contemporary model of the pathogenesis of atherosclerosis is based on the hypothesis that local damage of the endothelium together with systemic factors such as hypercholesterolemia, hyperglycemia, hypertension, chronically infections, genetic factors, diabetes mellitus, initiate a cascade of processes which eventually cause atherosclerotic lesion development 1, 2 . Although various hypotheses are already known about the pathogenesis of atherosclerosis and different factors of predisposition have been studied, from the point of molecular and vascular biology to clinical presentations and therapy methods, in modern literature there are still opposing views about the initial moment in the pathogenesis of this condition, regarding its functional and morphological changes.
The stage of the initial lesion -early lesion (type I)

Activation of endothelium
The initial stage, which precedes the development of atherosclerosis, is endothelial dysfunction, namely, activation of endothelial cells as a specific response to the action of harmful agents. Acute response of endothelium results in inflammation, coagulation disorders and vasomotor changes. The release of inflammation mediators deposited in the Weibel Palade bodies represents a very quick response of endothelial cells 3 . One of the most important consequences of endothelial activation is a decreased NO production, which causes the absence of its antiatherogenic, antiproliferative and vasodilatatory effects and, also, causes an increased production of endothelin-1 (ET-1) which in turn, through its mitogenic effect, stimulates proliferation of smooth muscle cells (SMCs) in the intima, and consequently initiate atherosclerosis 4, 5 . During activation of endothelial cells, changes in the process of coagulation have also been observed. Endothelial cells modulate their phenotype from anticoagulative to procoagulative, through an increased expression of tissue factors, or increased release of tissue plasminogen 6, 7 . Besides alterations in tonus and coagulation, endothelial activation includes increased expression of adhesive proteins (P-selectin, integrins) which promote the adhesion of leukocytes on endothelium and their infiltration in the subendothelial connective tissue 8 . This results in the release of free radicals, proteases and elastases which lead to further damage of endothelial cells 7 .
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wall, as a consequence of hypercholesterolemia, coupled with systemic hypertension. Lipid droplets bind to proteoglycans in the intimal connective tissue and have a tendency to form aggregates 9 . Lipoproteins in the lipid droplets may oxidize or become chemically modified in other ways 10, 11 .
Hypothesis of oxidative modification
Oxidative modification is the best researched study about the modification of lipoproteins (LDL) in atherosclerosis. Studies showed that oxidized LDL (ox-LDL) has been intensely absorbed in the culture of macrophages, partially through SR-A receptor, but in a larger part through other scavenger receptors, especially CD36. Circulating monocytes express SR-A and CD36, but at a lower degree. However, when monocyte enters into vascular wall and transforms to macrophage, during this transformation the expression of scavenger receptors is increased, and this allows absorption of modified LDL forms 12 . The rate of production of ox-LDL in the arterial intima is related to the concentration of native LDL. Concentration of native LDL in the intima depends on its concentration in plasma. These results have shown that possible predilected places for pathogenesis of atherosclerotic lesions could be thickenings of the intima on the proximal parts of the artery, after their branching or bifurcation 13 . Furthermore, it has been experimentally approved that the concentration of LDL in the vascular intima is higher in places where atherosclerosis will develop, compared to the places which are resistant 14 . It is interesting that permeability of the overlying endothelium is not increased, which means that LDL somehow selectively accumulates in those places. It is proven that LDL in these predilection places binds to proteoglycans of extracellular matrix 9 . Lipid droplets binded to proteoglycans in this way oxidize much more easily [15] [16] [17] . Also according to the literature, genetically engineered LDL does not bind to proteoglycans, which means it is less pathogenic than native LDL 18 . The presence of SMCs of synthetic phenotype contributes to the accumulation of LDL in intima. The number of these cells is increased in initial lesions; they act as fibroblasts and synthesize large amounts of proteoglycans. Previously presented facts suggest that the accumulation of LDL in intima could be the initial step in the pathogenesis of atherosclerotic lesion 16, 17 . At the initial lesions beside the increased expression of the vascular cell adhesion molecule-1 (VCAM-1), which selectively promotes the adhesion of lymphocytes and monocytes, ox-LDL itself contributes to the adhesion of these cells on the endothelial layer 18 . Oxidized LDL has cytotoxic effect on endothelial cells, acts as a mitogen of macrophages and SMCs and stimulates the release of monocyte chemoattractant protein-1 (MCP-1) and monocyte colony-stimulated factor (M-CSF) from endothelial cells, which directly starts chemotaxis and migration of monocytes into the subendothelial layer 19 . Degradation of polyunsaturated fatty acids in sn-2 place of phospholipids in LDL generates ox-LDL. After generation, ox-LDL binds to proteoglycans and becomes uptaken by macrophages through scavenger receptors 20 .
Expression of adhesion molecules in atherosclerosis
After initiation by hypercholesterolemia, leukocytes (at first, monocytes and T lymphocytes) adhere to the endothelium and actively migrate both, between and through endothelial cells into the intima 21 . In the subendothelium of the intima monocytes begin to accumulate lipids and begin transforming into foam cells. In that manner, increased expression of adhesion molecules, as a consequence of endothelial dysfunction and the accumulation of lipid droplets in the intima, promote adhesion of leukocytes to the endothelial layer and their migration into the subendothelium, in the initial and advanced stages of atherosclerosis [22] [23] [24] . A variety of adhesion molecules have been identified as important for this process. These include immunoglobulin superfamily members intercellular adhesion molecules 1 and 2 (ICAM-1 and ICAM-2), vascular cell adhesion molecule 1 (VCAM-1), platelet-endothelial cell adhesion molecule-1 (PECAM-1), as well as E-, P-and L-selectin 21, 25, 26 . Increased expression of VCAM-1 is a characteristic of an initial stage of atherosclerosis. This molecule interacts with specific integrin, very late antigen-4 (VLA-4), which is expressed only on monocytes and lymphocytes 25, 27 . As a result of this fact, at the initial stage of atherosclerosis, monocytes and T cells adhere in a significantly higher percentage than other types of leukocytes 28, 29 . On the other hand, ICAM-1 allows adhesion of a number of different leukocytes, because it interacts with CD11a (LFA-1) and CD11b (Mac-1) integrins on their membranes, and its expression is a characteristic of advanced atherosclerotic lesions 25, 27 . E-selectin (previously ELAM-1) is a typical representative of this group of adhesion molecules. Its name derives from a specific expression only on endothelial cells. Its increased expression is a characteristic of the advanced atherosclerotic lesions. This molecule interacts with Sialyl-Lewis X ligand on the membrane of granulocytes and memory T cells and due to this fact, at the advanced atherosclerotic lesions, these cells adhere to endothelial layer in a significantly higher percentage 25, 27 . P-selectin (previously GMP-140) is expressed primarily in thrombocytes, but also in overlying endothelium above atherosclerotic lesions. This molecule interacts with P-selectin glycoprotein ligand-1 (PSGL-1) on monocytes, lymphocytes and granulocytes. It has a significant role in "rolling" of leukocytes on endothelial layer above the lesion [30] [31] [32] . L-selectin is expressed on leukocytes and interacts with PSGL-1 ligand on monocytes, lymphocytes and granulocytes, but also with mucosal vascular addressin cell adhesion molecular link-1 (MAdCAM-1) 25, 27, 31 . In the endothelium above an atherosclerotic plaque, in the sites of infiltration of macrophages, there is a noticeable increase of expression of ICAM-1 and P-selectin 21, 23, 30 . These results indicate that the accumulation of monocytes which will later transform into macrophages partially dependes on synergic action of P-selectin and ICAM-1 on the endothelial layer 31, 32 . Many factors combined can induce an expression of endothelial adhesion molecules in atherosclerosis 31 . These factors are ox-LDL, inflammatory cytokines and biomechanical strength of blood shear stress. In the tissue culture, it is noticeable that the treatment of endothelial cells with ox-LDL increases the expression of P-selectin, ICAM-1 and VCAM-1 32, 33 . Cytokines, including interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α), increase the infiltration of leukocytes through adhesion molecules 2 . Regarding biomechanical stimuli, it is shown that the regulation of ICAM-1 expression is under influence of blood flow 34 .
Migration of leukocytes through endothelial layer
When leukocytes adhere to endothelium, they must receive a signal in order to go through endothelium into the deeper layers of vascular wall. Two characteristic processes, selectin-mediated rolling and integrin-mediated adhesion, cooperate to promote active migration of leukocytes, both across endothelial cells (transendothelial migration) and by diapedesis. Rolling of leukocytes and migration into the vascular wall are the crucial first steps in the development of inflammation and atherosclerosis 21 . Contemporary concepts regarding direct migration of leukocytes include activation of special cytokines-chemokines. At the early stage of atherosclerosis, one of those cytokines, MCP-1 is being produced in the endothelial cells, as a response to ox-LDL and other stimuli 34, 35 . This cytokine directly starts chemotaxis and the migration of monocytes into the subendothelial layer. At this stage, subpopulations of intimal SMCs and endothelial cells also express M-CSF which also promotes chemotaxis of monocytes, their adhesion and differentiation to macrophages, regulate proliferation of macrophages and other types of cells, which is implicated in inflammatory-fibroproliferative response at the advanced stages of atherosclerosis. Oxidized LDL also stimulates endothelial cells to express granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). These growth factors affect differentiation, survival, proliferation, migration and metabolism of macrophages/granulocytes, and G-CSF and GM-CSF also affect migration and proliferation of endothelial cells [32] [33] [34] [35] . Other types of chemokines may also increase lymphocyte accumulation in plaque. In atherosclerotic lesion, overlying endothelium expresses three types of lymphocyteselective chemokines: interferon-inducible protein-10 (IP-10), interferon-inducible T-cell alpha chemoattractant (I-TAC) and monokine induced by interferon-γ (MIG). Interferon-γ which is present in the atherosclerotic lesion induces genes which code T cell hemoattractant protein family of chemokine, and subsequently, accumulation of T cells in plaque 36, 37 .
Foam cells of monocyte-macrophage lineage
When monocytes enter the intima of a vessel wall, they undergo phenotype modification to macrophages. Macrophages then accumulate lipid droplets and become foam cells. The mechanism of cholesterol uptaking in macrophages is especially interesting.
Most of the cells use a plasma membrane receptor to uptake and release cholesterol. When a cell uptakes cholesterol for its own metabolic needs, a mechanism of the transcription control of this receptor become activated, which in turn shuts down the receptor expression and completely shuts down further absorption of cholesterol. On the contrary, macrophages in the atherosclerotic lesion (future foam cells) do not posses this kind of negative feedback, so it is obvious that they uptake cholesterol through some other kind of receptors 38 . Some investigations have shown that in the culture of macrophages in in vitro conditions, cells rapidly uptake modified, acetylated LDL, not through the known LDL receptor, but through the special "acetyl-LDL" receptor. Later, this receptor is cloned and called the scavenger receptor A (SR-A). Contrary to LDL receptor, expression of SR-A is not down-regulated as a response to the increased intracellular concentration of cholesterol. Theoretically, this kind of receptor might have a role in forming foam cells, because there is no data that acetyl-LDL has been generated in in vivo conditions 39, 40 . According to literature, the various modified forms of LDL also could have a role in the creation of foam cells, which brings out the question of the existence of various receptors 41, 42 . Other studies [42] [43] [44] have shown that some foam cells originate from SMCs, probably due to the fact that SMCs can also express scavenger receptors if they are properly activated, which will be discussed later.
Cytohistological characteristics of an initial lesionearly lesion (type I)
The results of a large number of recent studies on cytohistological characteristics of atherosclerotic lesions have shown that at the stage of initial lesion (early lesion -type I) there are no visible morphological changes in the structure of vascular wall, which is in accordance with the previously stated pathogenic mechanisms. According to these results, at the initial stage endothelial continuity is preserved, with the presence of individual foam cells and T cells in the intima. At initial phases of lesions circulating monocytes are the main precursors to foam cells. Smooth muscle cells in the intima and media show contractile phenotype (Figure 1) . Their phenotype modulation from the contractile to synthetic phenotype can be noticed during the fatty streak stage 28, 45, 46 .
The fatty streak stage -early lesion (type II)
Cytohistological characteristics of the fatty streak stage -early lesion (type II)
With further development of atherosclerotic lesion, at the fatty streak stage (early lesion -type II) increase in the number of foam cells (Figure 2 ) and intense infiltration of T cells occurs. At this stage, lipid accumulation in foam cells forms fatty streaks. Endothelial layer is still morphologically preserved, although it is functionally damaged 46, 47 . Foam cells at this stage originate from macrophages ( Figure 3) 46, 47 . The fatty streak stage is also characterized by the presence of SMCs of synthetic phenotype, but they are not foam cells yet 29, 47 . 
Smooth muscle cells (SMCs)
The results of testing phenotypical status of SMCs of atherosclerotic lesions showed that from a fatty streak stage, the modified SMCs of synthetic phenotype form the dominant cell population 28 . The development of synthetic phenotype is followed by a reduction in myofilaments 29 . Smooth muscle cells of synthetic phenotype expressed α-smooth muscle actin (α-SMA) and vimentin, with a lack of expression of desmin 43, 48 . The loss of desmin expression with concurrent vimentin expression is the first sign in the process of switching from contractile to synthetic phenotype 43, 49 . According to the existing literature, vimentin is an intermediary filament that can be found in differentiated SMCs as well, but it is coexpressed there with desmin. With the loss of contractile phenotype and characteristic desmin expression (i.e. with switching of cells to synthetic phenotype), the expression of vimentin filaments can be noticed 28, 45, 50 . Switching of SMCs to synthetic phenotype is a main characteristic of vascular remodeling during the pathogenesis of atherosclerosis 48, 51 . Vascular remodeling is an adaptive process involving the adjustment of structure and function of blood vessels to long-term changes in hemodynamic conditions, especially to hypertension 45, 52 . Scientific reports prove that reactive -adaptive intimal proliferation ("early response" of the wall) during the process of vascular remodeling, does not have a mechanism of negative feedback and that it can be continued in the form of intimal hyperplasia. In the primary response to the conditions of increased pressure, there is a proliferation of endothelial cells in vascular wall. After endothelial proliferation, during a rather long period of time it is characterized by SMCs proliferation accompanied by vascular wall thickening. The increased synthesis of collagen and elastin, which is an alteration of gene expression for the synthesis of these proteins, is the explanation for rapid enlargement and irreversible thickening in atherosclerotic vascular remodeling, in spite of apoptosis which is activated after proliferation of SMCs 52, 53 . Under the influence of chemotactic factors, SMCs migrate through fenestrae of the internal elastic lamina. As they express specific integrins (α2β1 which binds collagen and α3β1 and α5β1 which bind fibronectin) and elastin binding proteins on plasma membrane, they come in contact with connective tissue components and start to proliferate as a response to the stimuli of platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs) 55 . At the same time, under the influence of TGF-β, SMCs begin to secrete extracellular matrix components, thereby increasing the amount of collagen IV and collagen V. These changes were associated with up regulation of transforming growth factor β (TGF-β) 52 . Also, at this stage, adventitial myofibroblasts start to show the characteristics of contractile SMCs 29, 47, 48 . According to the same data, the increased expression of TGF-β in adventitia is the signal for differentiation of fibroblasts (which start to express α-SMA and the other markers of SMCs differentiation as well) and their migration, which makes it hard to differentiate from medial SMCs (Figure 4) . . Bifunctional growth factors, TGF-β and TNF-α, also have an influence on the proliferation and migration of SMCs. A multifunctional cytokine is TGF-β, which in its inactive form is being synthesized by endothelial cells and SMCs. This cytokine becomes activated under the influence of plasmin and induces differentiation of endothelial cells and SMCs, but paradoxically inhibits their migration and proliferation. TNF-α is cytokine which inhibits proliferation of endothelial cells and SMCs but it stimulates the transcription of heparin-binding EGF-like growth factor (HB-EGF) in SMCs 31, 54 . Each of these factors may influence the growth of SMCs or endothelial cell, both as a stimulant or inhibitor.
The preatheroma stage -intermediary lesion (type III)
Cytohistological characteristics of the preatheroma stage -intermediary lesion (typeIII)
At the preatheroma stage -intermediary lesion (type III), lipid accumulation surpasses the accumulation by foam cells and subendothelial layer contain scattered collections of extracellular lipid droplets and particles in the form of small isolated pools of extracellular lipid. The preatheroma stage is characterized by the presence of intimal and medial proliferating SMCs of synthetic phenotype ( Figure 5 ). The phenotype modulation of intimal and medial SMCs (based on the loss of desmin expression and the appearance of vimentin expression) begins at the fatty streak stage, and at the preatheroma stage these cells form the dominant cell population 28, 29, 45 . 
Foam cells of smooth muscle cells origin
The results of many studies have shown that SMCs of synthetic phenotype, proliferate and start to accumulate lipids from the fatty streak stage, but their largest number can be observed at the preatheroma stage 28, 29, 45 . According to the same data, some foam cells in atherosclerosis originate from SMCs of synthetic phenotype (express vimentinimmunoreactivity), probably due to the fact that some SMCs can also express scavenger receptors. Vimentin-immuno- reactivity points out to their syntetic/proliferative activity and also to their mesenchymal origin 45, 46 . The fact that SMCs express scavenger receptors and modulate to foam cells is possibly related to the embryonic origin of vascular SMCs 44 . All vascular SMCs have a mesenchymal origin, except for the fact that large arteries in the upper parts of the body can have the neuroectodermal origin 28, 56, 57 . Due to their mesenchymal origin, SMCs coexpress vimentin and desmin. During remodeling of vascular wall in atherosclerosis, there is a loss of contractile characteristics of SMCs and characteristic desmin expression so that SMCs of the synthetic phenotype express only vimentin 28, 29, 43 . After loss of contractile characteristics, SMCs proliferate and as a result of this proliferation start to intensively express S-100 protein. For both, SMCs of mesenchymal origin, as well as for SMCs of neuroectodermal origin, expression of this protein is a normal characteristic, but it is increased in processes which are Ca ++ -mediated. This protein in increased expression shows a high affinity to bind unsaturated lipid acids 58 . It has been assumed that SMCs due to their synthetic and proliferative activity can accumulate lipids.
Pathogenesis of atherosclerosis as an inflammatory response of vascular wall
Earlier theories about the pathogenesis of atherosclerosis have assumed hypercholesterolemia as a necessary condition for the development of this disease. Only in the later decades, numerous researches have pointed out to inflammation as a basis for pathogenesis of atherosclerosis 27 . As mentioned above, beginning with the initial lesion stage, in the response to the presence of modified lipids in the subendothelial layer, endothelial cells increase the expression of adhesion molecules, at first VCAM-1, which selectively promotes the adhesion of monocytes and T cells on endothelial layer. In response to the same stimulus endothelial cells express monocyteselective chemokine MCP-1 and three types of lymphocyte-selective chemokines (IP-10, I-TAC and MIG) which directly start chemotaxis and migration of monocytes and T cells into the subendothelial layer. The presence of macrophages and T cells in subendothelial layer show that the early stages of atherosclerotic lesion are an inflammatory response to exogenous pathogens 27, 51 . However, in addition to modified lipids, other exogenous pathogens, especially microorganisms, also promote inflammation. These antigens become presented by antigenpresenting cells (APCs), to Th CD4+ cells trough the MHC class II-dependent pathway. In response to immunological activation, mature forms of Th CD4+ cells begin to produce proinflammatory cytokines IL-2, IFN-γ and TNF-β. These cells also interreact with Tc CD8+ cells, NKT cells and macrophages, helping them to finish a started immune response against intracellural pathogens 27 . The role of APCs during atherosclerosis is played by macrophages, vascular dendritic cells (VDCs) and B cells, as a "professional APCs", but recent studies have show that low differentiated forms of SMCs also can process and present antigens 59, 60 . All APCs in vascular wall internalize antigens either by phagocytosis or by receptor-mediated endocytosis, and display a fragment of antigen bound to the class II MHC molecule on their plasma membrane. Expression of the antigen-class II MHC molecule complex which is a ligand for a T-cell receptor (TCR), on the membranes of APCs with additional co-stimulatory signals from APCs leads to immunological activation of T cells and manifestation of inflammatory reactions 27, 59, 60 . A great number of recent studies aimed to improve therapeutic procedures have been focused on the role of IFN-γ during atherosclerosis. Immediately after entrance into a subendothelial layer, T cells produce IFN-γ which induces genes that code T cell hemoattractant protein family of chemokine, and subsequently, further accumulation of T cells in the plaque. Besides, this cytokine activates macrophages immunoregulatory functions and simultaneously affects SMCs of a lesion. These literature data support the hypothesis that IFN-γ is a potent atherogenic cytokine, which significantly increases both, lesion size as well as the number of T lymphocytes within lesions, and also up regulates PDGF which causes an increased migration of smooth muscle cells 60, 61 .
If pathogenesis of atherosclerosis is viewed, in the light of these previously stated facts, as an inflammation, it can be concluded that during the early stages, atherosclerosis, as a specialized form of inflammation, responds to an injury of vascular wall and the presence of different pathogens 51 . With further progression of inflammatory reaction, during the stages of advanced atherosclerotic lesions, development of a chronic inflammatory fibroproliferative response occurs, which is histologically manifested as atheroma (type IV), lesion with a lipid core; fibroatheroma (type V), lesion with a lipid core and prominent fibrous connective tissue above it, or complicated atherosclerotic lesion that is defined as type IV or V lesions with disruptions of lesion surface, hematoma or hemorrhage, and developed thrombotic deposits ( Figures  7 and 8 ) 28, 45, 46, 48 . 
Conclusion
From all the previously presented facts we can conclude that the basic predisposing factor for development of atherosclerosis is hypercholesterolemia or infection, coupled with systemic hypertension.
The increased levels of plasma cholesterol promote the entrance of lipid droplets in subendothelial layer, their binding to proteoglycans and modification of LDL. Modified LDL stimulates increased expression of adhesion molecules and promotes the adhesion of leukocytes. Modified LDL also stimulates the production of cytokines-chemokines in endothelial cells which promotes the migration of leukocytes into the subendothelial layer, and also initiates synthesis of growth factors which affect differentiation, modulation, migration and proliferation of different cell types in the lesion. From the above presented facts we can conclude, too, that hypercholesterolemia starts circulus vitiosus in which many combined factors induce the development of inflammation in atherosclerosis. In addition to modified forms of LDL, the presence of other exogenous pathogens (especially microorganisms) initiates atherosclerosis through inflammatory response of vascular wall.
On the other hand, systemic hypertension promotes vascular remodeling. This process is characterized by smooth muscle cells phenotype modulation from contractile to synthetic phenotype, their migration from media into the subendothelial layer, their proliferation and collagen synthesis, as well as their transformation to foam cells in the presence of modified LDL, inflammatory cytokines and biomechanical strength of blood shear stress.
The previously analyzed facts suggest that atherosclerosis could be defined as inflammation which is a response to hypercholesterolemia or other exogenous pathogens, coupled with vascular remodeling, caused by systemic hypertension.
